Madeline Colli

The Southern Illinois University (SIU) Carbondale (Carbondale, Illinois) has formed a project that allows students to research the accuracy of Cannabidiol (CBD) products, ensuring consumers are receiving exactly what is found on CBD product labels.

Unrivaled Brands recently announced the launch of their new state of the art cultivation facility operating in Oakland, California.

Medical cannabis patients and adult-use consumers alike are faced with an overwhelming amount of options when they first enter a dispensary. Across the industry, producers are looking for ways to simplify things for consumers. One company, Volunteer Botanicals, recently partnered with an investment group to create cannabidiol (CBD)-based tablets that also combine other cannabinoids and have the potential to create a unique consumer experience. In this interview, Jason Pickle, co-founder and chief sales officer for Volunteer Botanicals, sits down to discuss this recent product, the need for standardization throughout the cannabis industry, and more.

When a patient is faced with a tough diagnosis, they often turn to their medical providers for the best treatment options. The troubling fact facing our healthcare professional is that they are not taught about the potential benefits of medicinal cannabis. This knowledge gap leaves a lot to be discovered by patients themselves who are seeking alternative treatments. After experiencing this firsthand with a family member, Katherine Golden, founder and CEO of Leaf411, decided to take action and help educate a community that was so in need of reliable and trustworthy information. Here, Golden shares her background, goals for Leaf411, and more.

Dewey Scientific discovers the first powdery mildew resistant gene found in cannabis.

September 14—Baltimore, Maryland—Dr. Denise Vidot, University of Miami, will give a keynote talk tomorrow in the medical cannabis meeting room 314–315 at 10:50 a.m. The talk is titled “Cannabinoids and the Brain-Heart-Gut Axis: Informing Science from an Epidemiological Lens.”

September 14—Baltimore, Maryland— Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”

September 13—Baltimore, Maryland— Dr. Dustin Sulak, co-founder of Healer, will give a keynote talk tomorrow in the medical cannabis meeting room 314–315 at 10:00 a.m. The talk is titled “Cannabis in Integrative Medicine, Health Promotion, and Disease Prevention.”

The publication's first and second print issues were nominated in the "Eddies-Magazine Launch-B2B” category of the annual awards program.

The COVID-19 pandemic affected all types of businesses, such as those found in the cannabis industry. Though it was hit hard from the virus, the cannabis industry suffered another blow in the form of the December 2020 COVID-19 stimulus package, which included a provision classifying all vape products as cigarettes, subjecting them to the same regulations as cigarettes. Here, U.S. Navy veteran Dana E. Shoched, president and chief executive officer of O2VAPE, discusses the impacts this legislation may have on the cannabis vaping industry.

Recently, the National Assembly of Panama voted to approve the legalization of medical cannabis, becoming the First Nation in Central America to do so.

Cannabis’s biggest antagonist is the stigma that surrounds it. Whole plant medicine has the potential to significantly benefit the pharmaceutical industry by complementing their efforts to bring patients relief from their ailments. Systems dynamics consultant/researcher, Ruth Fisher, PhD, explains how cannabis has the option to flourish but needs to stop having its efforts for growth and research hampered by opinions.

At a young age, Jari Sugano’s daughter, MJ, was diagnosed with Dravet syndrome. Standard pharmaceuticals didn’t help in alleviating her daughter's seizures. Here, Sugano talks about how medical cannabis has helped MJ and the importance of the caregiver role.

Nurse Janna Champagne shares her passion for educating patients, her peers, and more.

In this interview, Carl Esprey, CEO of Botanical Holdings speaks on the company’s path in the industry, the European cannabis industry and what the US can learn from other countries and more.

Pepper Hernandez, a doctor of naturopathic medicine, board-certified holistic health practitioner, PhD in transpersonal psychology, and the CEO and founder of the Cannabis Holistic Institute, shares her experiences as a medical cannabis patient turned educator.

Cannabis Science and Technology® is pleased to announce the addition of Eberhardt Kuhn, PhD, to its editorial advisory board (EAB).

Artelo Biosciences, Inc., recently announced the publication of study results in the peer-reviewed journal Medical Cannabis and Cannabinoids, comparing the in vitro effects of purified natural and synthetic forms of cannabidiol (CBD) to establish any pharmacological difference in human cell lines.

A recent article published by FiveThirtyEight (1) was highlighted on major news networks across the US, bringing attention to a very important issue facing the cannabis industry: how much tetrahydrocannabinol (THC) is actually in products. Here, we highlight some of the findings from the FiveThirtyEight report and what it means for the cannabis industry.

WeedMD, a federally licensed producer and distributor or medical-grade cannabis, will be rebranding as Entourage Health Corp. over the next few months.

Here, Otha Smith discusses the Tetragram app, which allows users to track cannabis products enabling them to find the best products that suit their needs.

As successful owners of the medical cannabis dispensary Greenhouse Wellness, Gina Dubbé and OBGYN Dr. Leslie Apgar share their history and future plans.

NFL-NFLPA Joint Pain Management Committee (PMC) plans to award up to $1 million in grants to CBD and cannabis researchers.

Cannabis Patient Care™ is pleased to announce the addition of Dr. Jeff Konin to its editorial advisory board (EAB).

In this interview, Michael Salaman, co-founder and president of GrowGeneration, talks about the trends in cannabis during the COVID-19 pandemic and more.

A recent study revealed how combining neurotechnology with saliva testing can reduce the chances of falsely claiming cannabis impairment due to THC.

In this interview, Maria Enquist-Newman, PhD, Director of R&D Program Management at Demetrix, delves into the specifics of fermentation-produced cannabinoids and how this method can benefit the cannabis industry.

British Journal of Pharmacology published a study' findings that highlighted the ability of Neuropathix’s patented compound KLS-13019 to prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in mice.

The publication's first print issue was nominated in the Best Subject-Related Package category of the annual awards program.

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.